Table 2.
Mental health and quality of life predicted by menopause symptom type.
| Variables | b | [95%CI] | β | t value | Adj. R2 | f 2 d |
|---|---|---|---|---|---|---|
| CES-D | ||||||
| MRS Total | b= .29 | [.19–.39] | β = .40 | t = 5.79 b | .19 | .23 |
| Psychological | b= .71 | [.50–.93] | β = .43 | t =6.55c | .22 | .28 |
| Somato- | b=.64 | [.38–.89] | β = .34 | t =4.95c | .15 | .18 |
| Urogenital | b=.38 | [.10–.65] | β = .19 | t =2.70 | .08 | .09 |
| PSQI | ||||||
| MRS Total | b= .21 | [.14–.27] | β = .41 | t = 6.00 b | .27 | .37 |
| Psychological | b= .48 | [.32–.63] | β = .41 | t = 6.19c | .28 | .39 |
| Somato- | b= .46 | [.29–.64] | β = .36 | t = 5.36c | .24 | .32 |
| Urogenital | b= .32 | [.14–.51] | β = .25 | t = 3.46c | .17 | .20 |
| BES | ||||||
| MRS Total | b= .01 | [.01–.02] | β =.23 | t =3.38 b | .23 | .30 |
| Psychological | b= .02 | [.01–.04] | β = .18 | t =2.60 | .19 | .23 |
| Somato- | b= .03 | [.01–.05] | β =.19 | t =2.78 | .19 | .23 |
| Urogenital | b= .04 | [.02–.06] | β =.27 | t =4.20c | .25 | .33 |
| Limits Ea | ||||||
| MRS Total | b= −.91 | [−1.50 to −.31] | β = −.22 | t = −3.00 b | .11 | .12 |
| Psychological | b= −2.31 | [−3.63 to −1.0] | β = −.24 | t = −3.47c | .13 | .15 |
| Somato- | b= −2.43 | [−3.91 to −.95] | β = −.23 | t = −3.23c | .13 | .15 |
| Urogenital | b= −.52 | [−2.09 to 1.06] | β = −.05 | t = −.65 | .07 | .08 |
| Vitalitya | ||||||
| MRS Total | b= −.74 | [−1.09 to −.39] | β = −.28 | t = −4.18 b | .24 | .32 |
| Psychological | b= −1.84 | [−2.62 to −1.06] | β = −.30 | t = −4.63c | .26 | .35 |
| Somato- | b= −1.61 | [−2.50 to −.71] | β = −.23 | t = −3.53c | .23 | .30 |
| Urogenital | b= −.99 | [−1.92 to −.05] | β = −.14 | t = −2.08 | .18 | .22 |
| Wellbeinga | ||||||
| MRS Total | b= −.84 | [−1.13 to −.56] | β = −.39 | t = −5.77 b | .20 | .25 |
| Psychological | b= −2.07 | [−2.70 to −1.44] | β = −.42 | t = −6.46c | .24 | .32 |
| Somato- | b= −1.81 | [−2.55 to −1.06] | β = −.32 | t = −4.77c | .17 | .20 |
| Urogenital | b= −1.11 | [−1.91 to −.32] | β = −.20 | t = −2.76 | .09 | .10 |
| Social Functiona | ||||||
| MRS Total | b= −.70 | [−1.08 to −.32] | β = −.26 | t = −3.60 b | .12 | .14 |
| Psychological | b= −2.29 | [−3.11 to −1.47] | β = −.37 | t = −5.50c | .19 | .23 |
| Somato- | b= −1.59 | [−2.57 to −.61] | β = −.23 | t = −3.21 | .11 | .12 |
| Urogenital | b= −.40 | [−1.42 to .62] | β = −.06 | t = −.77 | .06 | .06 |
| Paina | ||||||
| MRS Total | b= −1.06 | [−1.44 to −.68] | β = −.37 | t = −5.50 b | .23 | .30 |
| Psychological | b= −2.11 | [−2.96 to −1.26] | β = −.33 | t = −4.88c | .20 | .25 |
| Somato- | b= −2.80 | [−3.74 to −1.86] | β = −.38 | t = −5.87c | .23 | .30 |
| Urogenital | b= −1.59 | [−2.62 to −.56] | β = −.21 | t = −3.03 | .14 | .16 |
| General Healtha | ||||||
| MRS Total | b = −.80 | [−1.23 to −.38] | β = −.34 | t = −3.75 b | .18 | .22 |
| Psychological | b = −1.58 | [−2.49 to −.67] | β = −.31 | t = −3.44c | .16 | .19 |
| Somato- | b = −1.97 | [−3.00 to −.93] | β = −.33 | t = −3.75c | .18 | .22 |
| Urogenital | b = −1.12 | [−2.47 to .23] | β = −.16 | t = −1.65 | .10 | .11 |
Note: CES-D = Center for Epidemiologic Studies – Depression Scale; BES = Binge Eating Scale; PSQI = Pittsburgh Sleep Quality Index; Limits E = role limitations due to emotional health; Somato- = Somato-vegetative; Bold indicates MRS total results; MRS higher = more severe symptoms; Adj. R2 accounts for all covariates and the independent variable entered into the model; All models are controlling for: psychiatric history, education, partner status, time since menopause, Body Mass Index, and hormone therapy
higher indicates better QOL
p < .004; Adjusted for multiple observations on each participant. A Bonferroni correction for multiple variable comparisons would consider p < .004 as statistically significant.
p < .001; Adjusted for multiple observations on each participant. A Bonferroni correction for multiple variable comparisons would consider p < .001 as statistically significant.
Cohen’s f2 as estimate of effect size: 0.02 = small, 0.15 = medium, 0.35 = large